Cargando…

Sialylation on O-linked glycans protects von Willebrand factor from macrophage galactose lectin-mediated clearance

Terminal sialylation determines the plasma half-life of von Willebrand factor (VWF). A role for macrophage galactose lectin (MGL) in regulating hyposialylated VWF clearance has recently been proposed. In this study, we showed that MGL influences physiological plasma VWF clearance. MGL inhibition was...

Descripción completa

Detalles Bibliográficos
Autores principales: Ward, Soracha E., O’Sullivan, Jamie M., Moran, Alan B., Spencer, Daniel I. R., Gardner, Richard A., Sharma, Jyotika, Fazavana, Judicael, Monopoli, Marco, McKinnon, Thomas A. J., Chion, Alain, Haberichter, Sandra, O’Donnell, James S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883566/
https://www.ncbi.nlm.nih.gov/pubmed/33763999
http://dx.doi.org/10.3324/haematol.2020.274720
_version_ 1784659966715494400
author Ward, Soracha E.
O’Sullivan, Jamie M.
Moran, Alan B.
Spencer, Daniel I. R.
Gardner, Richard A.
Sharma, Jyotika
Fazavana, Judicael
Monopoli, Marco
McKinnon, Thomas A. J.
Chion, Alain
Haberichter, Sandra
O’Donnell, James S.
author_facet Ward, Soracha E.
O’Sullivan, Jamie M.
Moran, Alan B.
Spencer, Daniel I. R.
Gardner, Richard A.
Sharma, Jyotika
Fazavana, Judicael
Monopoli, Marco
McKinnon, Thomas A. J.
Chion, Alain
Haberichter, Sandra
O’Donnell, James S.
author_sort Ward, Soracha E.
collection PubMed
description Terminal sialylation determines the plasma half-life of von Willebrand factor (VWF). A role for macrophage galactose lectin (MGL) in regulating hyposialylated VWF clearance has recently been proposed. In this study, we showed that MGL influences physiological plasma VWF clearance. MGL inhibition was associated with a significantly extended mean residence time and 3-fold increase in endogenous plasma VWF antigen levels (P<0.05). Using a series of VWF truncations, we further demonstrated that the A1 domain of VWF is predominantly responsible for enabling the MGL interaction. Binding of both full-length and VWF-A1-A2-A3 to MGL was significantly enhanced in the presence of ristocetin (P<0.05), suggesting that the MGL-binding site in A1 is not fully accessible in globular VWF. Additional studies using different VWF glycoforms demonstrated that VWF O-linked glycans, clustered at either end of the A1 domain, play a key role in protecting VWF against MGLmediated clearance. Reduced sialylation has been associated with pathological, increased clearance of VWF in patients with von Willebrand disease. Herein, we demonstrate that specific loss of α2-3 linked sialylation from O-glycans results in markedly increased MGL-binding in vitro, and markedly enhanced MGL-mediated clearance of VWF in vivo. Our data further show that the asialoglycoprotein receptor (ASGPR) does not have a significant role in mediating the increased clearance of VWF following loss of O-sialylation. Conversely however, we observed that loss of N-linked sialylation from VWF drives enhanced circulatory clearance predominantly via the ASGPR. Collectively, our data support the hypothesis that in addition to regulating physiological VWF clearance, the MGL receptor works in tandem with ASGPR to modulate enhanced clearance of aberrantly sialylated VWF in the pathogenesis of von Willebrand disease.
format Online
Article
Text
id pubmed-8883566
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-88835662022-03-18 Sialylation on O-linked glycans protects von Willebrand factor from macrophage galactose lectin-mediated clearance Ward, Soracha E. O’Sullivan, Jamie M. Moran, Alan B. Spencer, Daniel I. R. Gardner, Richard A. Sharma, Jyotika Fazavana, Judicael Monopoli, Marco McKinnon, Thomas A. J. Chion, Alain Haberichter, Sandra O’Donnell, James S. Haematologica Article Terminal sialylation determines the plasma half-life of von Willebrand factor (VWF). A role for macrophage galactose lectin (MGL) in regulating hyposialylated VWF clearance has recently been proposed. In this study, we showed that MGL influences physiological plasma VWF clearance. MGL inhibition was associated with a significantly extended mean residence time and 3-fold increase in endogenous plasma VWF antigen levels (P<0.05). Using a series of VWF truncations, we further demonstrated that the A1 domain of VWF is predominantly responsible for enabling the MGL interaction. Binding of both full-length and VWF-A1-A2-A3 to MGL was significantly enhanced in the presence of ristocetin (P<0.05), suggesting that the MGL-binding site in A1 is not fully accessible in globular VWF. Additional studies using different VWF glycoforms demonstrated that VWF O-linked glycans, clustered at either end of the A1 domain, play a key role in protecting VWF against MGLmediated clearance. Reduced sialylation has been associated with pathological, increased clearance of VWF in patients with von Willebrand disease. Herein, we demonstrate that specific loss of α2-3 linked sialylation from O-glycans results in markedly increased MGL-binding in vitro, and markedly enhanced MGL-mediated clearance of VWF in vivo. Our data further show that the asialoglycoprotein receptor (ASGPR) does not have a significant role in mediating the increased clearance of VWF following loss of O-sialylation. Conversely however, we observed that loss of N-linked sialylation from VWF drives enhanced circulatory clearance predominantly via the ASGPR. Collectively, our data support the hypothesis that in addition to regulating physiological VWF clearance, the MGL receptor works in tandem with ASGPR to modulate enhanced clearance of aberrantly sialylated VWF in the pathogenesis of von Willebrand disease. Fondazione Ferrata Storti 2021-03-25 /pmc/articles/PMC8883566/ /pubmed/33763999 http://dx.doi.org/10.3324/haematol.2020.274720 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Article
Ward, Soracha E.
O’Sullivan, Jamie M.
Moran, Alan B.
Spencer, Daniel I. R.
Gardner, Richard A.
Sharma, Jyotika
Fazavana, Judicael
Monopoli, Marco
McKinnon, Thomas A. J.
Chion, Alain
Haberichter, Sandra
O’Donnell, James S.
Sialylation on O-linked glycans protects von Willebrand factor from macrophage galactose lectin-mediated clearance
title Sialylation on O-linked glycans protects von Willebrand factor from macrophage galactose lectin-mediated clearance
title_full Sialylation on O-linked glycans protects von Willebrand factor from macrophage galactose lectin-mediated clearance
title_fullStr Sialylation on O-linked glycans protects von Willebrand factor from macrophage galactose lectin-mediated clearance
title_full_unstemmed Sialylation on O-linked glycans protects von Willebrand factor from macrophage galactose lectin-mediated clearance
title_short Sialylation on O-linked glycans protects von Willebrand factor from macrophage galactose lectin-mediated clearance
title_sort sialylation on o-linked glycans protects von willebrand factor from macrophage galactose lectin-mediated clearance
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883566/
https://www.ncbi.nlm.nih.gov/pubmed/33763999
http://dx.doi.org/10.3324/haematol.2020.274720
work_keys_str_mv AT wardsorachae sialylationonolinkedglycansprotectsvonwillebrandfactorfrommacrophagegalactoselectinmediatedclearance
AT osullivanjamiem sialylationonolinkedglycansprotectsvonwillebrandfactorfrommacrophagegalactoselectinmediatedclearance
AT moranalanb sialylationonolinkedglycansprotectsvonwillebrandfactorfrommacrophagegalactoselectinmediatedclearance
AT spencerdanielir sialylationonolinkedglycansprotectsvonwillebrandfactorfrommacrophagegalactoselectinmediatedclearance
AT gardnerricharda sialylationonolinkedglycansprotectsvonwillebrandfactorfrommacrophagegalactoselectinmediatedclearance
AT sharmajyotika sialylationonolinkedglycansprotectsvonwillebrandfactorfrommacrophagegalactoselectinmediatedclearance
AT fazavanajudicael sialylationonolinkedglycansprotectsvonwillebrandfactorfrommacrophagegalactoselectinmediatedclearance
AT monopolimarco sialylationonolinkedglycansprotectsvonwillebrandfactorfrommacrophagegalactoselectinmediatedclearance
AT mckinnonthomasaj sialylationonolinkedglycansprotectsvonwillebrandfactorfrommacrophagegalactoselectinmediatedclearance
AT chionalain sialylationonolinkedglycansprotectsvonwillebrandfactorfrommacrophagegalactoselectinmediatedclearance
AT haberichtersandra sialylationonolinkedglycansprotectsvonwillebrandfactorfrommacrophagegalactoselectinmediatedclearance
AT odonnelljamess sialylationonolinkedglycansprotectsvonwillebrandfactorfrommacrophagegalactoselectinmediatedclearance